What is included in this Sample?
- * Market Segmentation
- * Key Findings
- * Research Scope
- * Table of Content
- * Report Structure
- * Report Methodology
Download FREE Sample Report
Sodium Starch Glycolate Market Size, Share, Growth, and Industry Analysis by Type [SSG (Corn Starch), SSG (Potato Starch) and SSG (Others)], By Application (Pharmaceutical Uses and Food Uses and Others ) Regional Forecast To 2033
Trending Insights

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels
SODIUM STARCH GLYCOLATE MARKET OVERVIEW
The global Sodium Starch Glycolate Market was valued approximately at USD 0.075 billion in 2024 and is projected to reach USD 0.08 billion in 2025, steadily progressing to USD 0.125 billion by 2033, with a CAGR of 5.9% from 2025 to 2033.
The global COVID-19 pandemic has been unprecedented and staggering, with the sodium starch glycolate market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.
Sodium starch glycolate is the sodium salt of carboxymethyl ether. Rice, potato, wheat, and maize starch glycolates are the most common. It is a white to off-white powder with no taste or odour. Sodium starch glycolate is a pharmaceutical grade dissolving excipient for tablets and capsules. It absorbs water quickly, causing swelling and rapid breakdown of tablets and granules. It is utilised as a disintegrant, a suspending agent, and a gelling agent. Without a disintegrant, tablets may not dissolve properly, affecting the amount of active component absorbed and hence limiting effectiveness. Sodium starch glycolate is also utilised in formulations with various filler-binders, such as mannitol and dicalcium phosphates.
COVID-19 IMPACT
The Up-veil of the COVID-19 Cases and Chronic Infections Led to Rapid Growth of the Market
The COVID-19 pandemic has had a significant impact on healthcare systems and drugs used to treat COVID-19 Infectious patients. The increased demand from the pharmaceutical sector, as a result of the rise in chronic and acute diseases, and the rising COVID-19 cases worldwide, is the primary growth driver. As a result, the pandemic had a escalating impact on the sodium starch glycolate market share.
LATEST TRENDS
The Utilization in the Automotive and Packaging Industry to Inflate the Market Demand
The expansion of the automotive industry has also increased the need for SSG, which is used in industrial-grade adhesives, which are widely used in the automobile industry. SSG is utilised as an addition in glues and is used in the automotive and packaging sectors. SSG is also used as a thickener in paint and as a stabilising agent in packaged foods. Additionally, the emphasis on personal hygiene and care is increasing, which drives the sodium starch glycolate market growth. Furthermore, companies are putting more emphasis on investing extensively in research and development related to the processing and optimal utilisation.
SODIUM STARCH GLYCOLATE MARKET SEGMENTATION
By Type
Based on type; the sodium starch glycolate market is divided into SSG (corn starch), SSG (potato starch) and SSG (others).
The part SSG (Corn Starch) is the leads the type segment.
By Application
Based on the application; the sodium starch glycolate market is divided into pharmaceutical uses and food uses and others.
The pharmaceutical uses is the leading part of the application segment.
DRIVING FACTORS
The Pharmaceutical Uses in Acute and Chronic Diseases to Multiply the Market Share Across the Globe
The pharmaceutical uses application is predicted to account for the highest share of the global market during the forecasted period due to its super disintegrating feature, which finds a wide range of applications in the pharmaceutical sector.As the incidence of chronic and acute ailments in the world has grown, so has the demand for medicines. Similarly, there are diseases and infections that require regular medicine to be confined, which increases the demand for tablet and capsule production.
As a pharmaceutical quality dissolution excipient for tablets and capsules, sodium starch glycolate is employed. It quickly absorbs water, causing bloating and fast breakdown of tablets and granules. It is employed as a disintegrant, suspending agent, and gelling agent. Tablets without a disintegrant may not dissolve properly, affecting the amount of active component absorbed and hence diminishing effectiveness. Sodium starch glycolate is also utilised in formulations with other filler-binders such mannitol and dicalcium phosphates.
The Primitive Utilization in Food and Cosmetics Sector to Enhance the Market Demand
There is a significant increase in the number of food joints and eateries, which will eventually increase demand for fast food and packaged food products (such as frozen snacks, ice cream, bread, and a variety of other food items), thereby accelerating the utilisation of Sodium Starch Glycolate and its supporting industries. It is also used in cosmetic goods due to its qualities such as longevity in moisturization and smoothness. In 2018, Roquette Co. announced the launch of the latest SSG product under the brand "Beauty by Roquette" for use in the cosmetics sector.
RESTRAINING FACTORS
The Stringent and Revised Norms and Standards to Restrict the Market Growth
The expansion of the sodium starch glycolate market may be hampered by the many food and drug associations in various nations, each of which has its own set of norms and criteria to follow before releasing a product to the market.a
SODIUM STARCH GLYCOLATE MARKET REGIONAL INSIGHTS
-
Request a Free sample to learn more about this report
North America to Lead the Market with Enormous Utilization and Escalating Market Players
With the largest market share, North America is likely to continue to dominate the industry over the course of the projection period.Because of the presence of several drug makers and biotechnology Pharma businesses in the United States, North America emerged as the main regional market. Rising chronic diseases as a result of changing lifestyles and strenuous work schedules are pushing the pharmaceutical industry's demand for diverse treatments.
Furthermore, according to the Pharmaceutical Research and Manufacturers' Association, U.S.A-based companies account for half of the world's pharmaceutical research and development, which is likely to fuel industry expansion. The recovery of the automobile industry and the expansion of the packaging industry in this region are expected to feed demand for adhesives, which will enhance demand for SSG in the region.
The presence of large biotechnological Pharma companies in the U.S.A is likely to boost demand for the SSG. Thus, such factors can lead to sustainable growth over the forecast period.
KEY INDUSTRY PLAYERS
Key Industry Players to Promote the Market Expansion
The market's expansion was significantly impacted by the techniques employed by market participants in recent years, such as extensions. The report covers details and information about the firms and their interactions with the market.
List of Top Sodium Starch Glycolate Companies
- DFE Pharma (India)
- JRS Pharma (Germany)
- Roquette Frères S.A. (France)
- Anhui Sunhere Pharmaceutical Excipients Co., Ltd. (China)
- Shreeji Pharma International (India)
- Liaocheng A Hua Pharmaceutical Co., Ltd (China)
- Prachin Chemical (India)
- QFTL Medical Suppliments (U.S.A)
- Xinda Biotechnology Co.,Ltd (China)
- Huzhou Zhanwang Pharmaceutical Co.,Ltd (China)
- Muby Chemicals (India)
- Yung Zip Chemical Ind. Co., Ltd. (China)
REPORT COVERAGE
This report covers a comprehensive backdrop analysis, an assessment of the parent market, intensive study in the market dynamics. Past historical, current, and projected size of the market from the point of both value and volume. Researching of recent industry developments, deep study on market shares and strategies of major players and the emerging niche segments and regional market areas are covered in the report.
Attributes | Details |
---|---|
Market Size Value In |
US$ 0.075 Billion in 2024 |
Market Size Value By |
US$ 0.125 Billion by 2033 |
Growth Rate |
CAGR of 5.9% from 2025 to 2033 |
Forecast Period |
2025-2033 |
Base Year |
2024 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
|
By Type
|
|
By Application
|
FAQs
The global Sodium Starch Glycolate Market is expected to touch USD 0.125 billion in 2033.
The Sodium Starch Glycolate Market is expected to exhibit a CAGR of 5.9% by 2033.
The North American region leads the sodium starch glycolate market.
The pharmaceutical uses in chronic, acute diseases and the primitive utilization in the food and cosmetics sector are the driving factors of the sodium starch glycolate market.
DFE Pharma, JRS Pharma, Roquette Freres S.A., Anhui Sunhere Pharmaceutical Excipients Co., Ltd., Shreeji Pharma International, Liaocheng A Hua Pharmaceutical Co., Ltd, Prachin Chemical, QFTL Medical Suppliments, Xinda Biotechnology Co.,Ltd, Huzhou Zhanwang Pharmaceutical Co.,Ltd, Muby Chemicals, Yung Zip Chemical Ind. Co., Ltd. and others are the top companies operating in the sodium starch glycolate market.